EZH2 activating mutations or copy number alterations in melanoma result in transcriptional silencing of tumor suppressor genes, immune response genes, and differentiation factors, contributing to poorer overall survival and metastasis-free survival7,8,25,26,29,30. The gene discussed is EZH2; the disease is melanoma.